NCCM
CPXX

Nine Chapters Capital Management’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Nine Chapters Capital Management’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-47,400
Closed -$106K – 1316
2015
Q2 		$106K Buy
+47,400
New +$107K 0.01% 873

Other funds holding CPXX

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nine Chapters Capital Management's CPXX Position: Q3 2015 in Review

Nine Chapters Capital Management sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2015, closing a stake of 47,400 shares — an estimated $106K sold.

Nine Chapters Capital Management first reported a position in CPXX in Q2 2015 and held it in 1 quarter. The position peaked at $106K in Q2 2015. 20 funds tracked by Wall St. Rank hold CPXX as of Q3 2015.

  • Nine Chapters Capital Management reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2015 after selling out during the quarter.
  • Nine Chapters Capital Management sold 47,400 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2015, an estimated $106K.
  • Nine Chapters Capital Management first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2015 and held it in 1 quarter.
  • Nine Chapters Capital Management's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $106K in Q2 2015.
  • 20 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2015.

Based on Nine Chapters Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.